|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-3-27
|
|
pubmed:abstractText |
Some studies have suggested that women with metastatic malignant melanoma have a better survival rate than men. However, little is known about the effect of gender on survival in combination with other clinical variables and treatment variables. Thus, an analysis of 813 eligible patients from 15 consecutive Southwest Oncology Group (SWOG) Phase II or III trials evaluating chemotherapy or chemoimmunotherapy for metastatic melanoma was performed.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2001 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
91
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1148-55
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11267960-Adolescent,
pubmed-meshheading:11267960-Adult,
pubmed-meshheading:11267960-Aged,
pubmed-meshheading:11267960-Aged, 80 and over,
pubmed-meshheading:11267960-Clinical Trials as Topic,
pubmed-meshheading:11267960-Disease Progression,
pubmed-meshheading:11267960-Disease-Free Survival,
pubmed-meshheading:11267960-Female,
pubmed-meshheading:11267960-Health Status,
pubmed-meshheading:11267960-Humans,
pubmed-meshheading:11267960-Male,
pubmed-meshheading:11267960-Melanoma,
pubmed-meshheading:11267960-Middle Aged,
pubmed-meshheading:11267960-Neoplasm Invasiveness,
pubmed-meshheading:11267960-Prognosis,
pubmed-meshheading:11267960-Retrospective Studies,
pubmed-meshheading:11267960-Risk Factors,
pubmed-meshheading:11267960-Sex Factors,
pubmed-meshheading:11267960-Skin Neoplasms,
pubmed-meshheading:11267960-Survival Analysis
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials.
|
|
pubmed:affiliation |
Southwest Oncology Group Statistical Center, Seattle, Washington , USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Multicenter Study,
Meta-Analysis
|
